港股雲知聲(09678.HK)短線走高，現漲超3%。此前媒體報道雲知聲正研究回A可能性。

The National Medical Products Administration, via its priority review channel, has granted conditional approval to Chengdu Bailiduote Biopharma Co., Ltd.'s injectable monoclonal antibody Lunkangyilongtuo (trade name Yizekang). Indication: adults with recurrent or metastatic nasopharyngeal carcinoma who progressed after at least two lines of systemic chemotherapy and prior PD‑1/PD‑L1 inhibitor therapy. The approval adds a new treatment option for this patient cohort.

A股券商股拉昇，廣發證券漲超8%，中信建投漲超7%，長江證券漲超6%，華泰證券漲超5%，中金公司、招商證券漲超3%。